Triple-Drug attack shows promise against blood cancer
NCT ID NCT03580928
First seen Feb 14, 2026 · Last updated Jun 12, 2026 · Updated 15 times
Summary
This study tested a combination of three drugs (acalabrutinib, venetoclax, and obinutuzumab) as a first treatment for people with chronic lymphocytic leukemia (CLL) who had not received prior therapy. The goal was to see if the combination could clear cancer cells from the bone marrow. A total of 72 participants took part. The approach aims to control the disease, but ongoing management may still be needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Lifespan Cancer Institute
Providence, Rhode Island, 02903, United States
-
Stamford Hospital/Bennett Cancer Center
Stamford, Connecticut, 06904, United States
Conditions
Explore the condition pages connected to this study.